Willis G, Jennings B, Ball R Y, New N E, Gibson I
Department of Biological Sciences, University of East Anglia, Norwich, England.
Gynecol Oncol. 1993 Jun;49(3):359-64. doi: 10.1006/gyno.1993.1140.
Paraffin-wax-embedded samples of normal cervical tissue and of primary cervical carcinomata and nodal metastases were obtained from each of 15 patients. They were analyzed for the presence of ras point mutations and human papillomavirus (HPV) types 16 and 18 using the polymerase chain reaction (PCR) and hybridization to oligomer probes. Only 1 patient was found to have a ras mutation: a codon 13 mutation of Ki-ras which was present in only two lymph node metastases, but not in the primary tumor or in a third metastasis. These results suggest that ras point mutation is not a common factor in the development of primary or metastatic cervical cancer. HPV 16 was detected in 7 of the 15 patients and was present in both primary and metastatic tumors in 6 of these 7 cases. HPV 18 was not detected in any of the 15 patients. These results do not suggest a role for HPVs 16 and 18 in producing metastatic behavior.
从15例患者身上获取了正常宫颈组织、原发性宫颈癌及淋巴结转移灶的石蜡包埋样本。使用聚合酶链反应(PCR)和与寡聚体探针杂交的方法,分析样本中ras点突变以及人乳头瘤病毒(HPV)16型和18型的存在情况。仅发现1例患者存在ras突变:Ki-ras基因第13密码子突变,仅在两个淋巴结转移灶中出现,而原发性肿瘤及第三个转移灶中均未出现。这些结果表明,ras点突变并非原发性或转移性宫颈癌发生发展的常见因素。15例患者中有7例检测到HPV 16,这7例中的6例其原发性肿瘤和转移瘤中均存在HPV 16。15例患者中均未检测到HPV 18。这些结果并不表明HPV 16和18在产生转移行为方面起作用。